PEN

#790
Penumbra, Inc. Common Stock
318.9 3 USD
-0.21%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
318.48
320.12
Range Annuel
3.19
362.41
Changement quotidien
-0.21%
Changement Mensuel
-2.06%
Evolution sur 6 mois
+7.89%
Changement Annuel
+22.67%
Clôture Précédente
319.6 0
Open
319.5 7
Low
318.4 8
High
320.1 2
Volume
88
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 12.54 B
  • Employee 4 700
  • Founded 2004
  • CEO Adam Elsesser
  • Website www.penumbrainc.com
  • Headquarter Delaware, United States
  • FIGI BBG001BP92V1
  • Industry Dispositifs Médicaux
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
68.79
ratio cours/chiffre d'affaires
8.7

Penumbra, Inc. Common Stock

Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm. In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by yearend.

Nouvelles